Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
solute carrier family 6 member 5 | 0.670 | 0.500 | 9.0E-15 |
|
phenotype | 0.420 | None | 1.000 | 0 | 0 | 2012 | 2015 | ||||||||
|
choline O-acetyltransferase | 0.520 | 0.808 | 5.6E-11 |
|
phenotype | 0.180 | None | 1.000 | 0 | 0 | 2001 | 2019 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
phenotype | 0.150 | None | 1.000 | 0 | 1 | 2005 | 2018 | ||||||||
|
alkaline phosphatase, biomineralization associated | 0.546 | 0.769 | 3.6E-04 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2011 | 2011 | ||||||||
|
solute carrier family 5 member 7 | 0.597 | 0.654 | 1.5E-02 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2016 | 2016 | ||||||||
|
ATPase Na+/K+ transporting subunit alpha 3 | 0.544 | 0.615 | 1.00 |
|
phenotype | 0.110 | None | 1.000 | 0 | 1 | 2018 | 2018 | ||||||||
|
paired like homeobox 2B | 0.565 | 0.731 | 0.94 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2014 | 2014 | ||||||||
|
glycine receptor alpha 1 | 0.628 | 0.500 | 1.6E-04 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2013 | 2013 | ||||||||
|
KIAA0586 | 0.565 | 0.731 | 5.1E-16 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
FAD dependent oxidoreductase domain containing 1 | 0.633 | 0.462 | 2.0E-16 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
arginyl-tRNA synthetase 2, mitochondrial | 0.663 | 0.462 | 7.7E-14 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
methylcrotonoyl-CoA carboxylase 1 | 0.700 | 0.308 | 4.0E-12 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
zinc finger C4H2-type containing | 0.561 | 0.731 | 0.91 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
prion protein | 0.445 | 0.923 | 6.3E-04 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
NADH:ubiquinone oxidoreductase subunit A12 | 0.659 | 0.462 | 7.4E-05 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
inositol polyphosphate-5-phosphatase E | 0.561 | 0.615 | 3.1E-03 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
coiled-coil and C2 domain containing 2A | 0.532 | 0.692 | 1.7E-27 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
transmembrane protein 237 | 0.612 | 0.538 | 1.9E-12 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
SKI proto-oncogene | 0.503 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
surfactant protein B | 0.575 | 0.654 | 2.6E-04 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
succinate dehydrogenase complex flavoprotein subunit A | 0.517 | 0.731 | 2.6E-10 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
sodium voltage-gated channel alpha subunit 2 | 0.518 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
NADH:ubiquinone oxidoreductase subunit S4 | 0.587 | 0.808 | 3.1E-04 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
peroxisomal biogenesis factor 5 | 0.561 | 0.731 | 5.6E-05 |
|
phenotype | 0.100 | None | 0 | 0 |